Johnson & Johnson launched a new late-stage trial in Britain on Monday to test a two-dose regimen of its experimental COVID-19 vaccine among thousands of volunteers, as the U.S. drugmaker expands its...
https://ift.tt/eA8V8J
https://ift.tt/eA8V8J
Comments
Post a Comment